Home Blog Page 16

An Authorial Course as a Form of Artistic Research

Adam
-
0
An Authorial Course as a Form of Artistic Research

 

Ekaterina Zaznova
Artist, educator, author of the “Watercolor & Alcohol” method,
Member of the Union of Russian Watercolorists (SAR), IWS, AWS, NWS, TWSA

Abstract

This article examines the authorial course as a form of artistic research, using as a case study the course “Watercolor & Alcohol”, developed and implemented by me in 2024–2025. The course is based on an original artistic methodology officially registered with the U.S. Copyright Office and combines experimental work with watercolor and isopropyl alcohol, elements of pedagogical design, and practices of visual self-inquiry. As part of a broader artistic–educational system, the course functions both as training and as artistic inquiry, confirming the relevance of authorial methodologies in contemporary visual education.

Keywords: authorial course, watercolor, alcohol, methodology, artistic research, pedagogy, visual education.

Introduction

Contemporary forms of art education are rapidly moving away from purely academic models toward flexible, author-driven approaches where the instructor’s personal practice becomes an integral part of the curriculum. In this context, it is important to consider the authorial course not merely as a means of skill transfer but as an instrument of artistic research—a platform in which teaching and creation develop in parallel.

The purpose of this article is to present my authorial course “Watercolor & Alcohol” as an example of such a research-based structure, to substantiate it as an independent methodological and artistic system, and to describe the principles on which it is built.

1. Initial Context and Motivation for Development

My work on the course began with my personal artistic practice, in which I systematically investigated the behavior of watercolor pigment in an alcohol environment. Through these creative experiments, I identified recurring patterns, including:

– Differences in pigment behavior at varying alcohol concentrations (30%, 50%, 99%)
– The influence of temperature and evaporation rate on watercolor dynamics
– The possibility of deliberately creating complex textures through controlled intervention with alcohol at various stages of drying

On the basis of this accumulated material, I began to formalize a personal system of artistic solutions, which subsequently developed into a methodology combining practice, experimentation, and an educational structure.

2. The Methodology as a System

The “Watercolor & Alcohol” methodology consists of several components:

  1. Alcohol-concentration modules (low, medium, pure), with analysis of resulting visual effects

  2. Genre adaptation: botanical, marine motifs, abstract compositions

  3. Variability of application forms: spraying, pouring, point intervention

  4. Phase-based work: wet-on-wet, semi-dry, and dry-layer processes

  5. Layer management: multilayering, glazing, and controlled lifting

  6. Tools: brushes, pipettes, sponges, spray bottles

The elements of the method are adapted to different skill levels—from beginner to professional. In contrast to academic courses, this approach does not limit students to a fixed set of techniques but engages them in personal artistic research, where outcomes may be unpredictable yet remain subject to visual analysis.

3. The Course as an Educational System

The course has been implemented on several international platforms (including Udemy), translated into English, and adapted for both individual and group online learning. It includes:

– Video lectures demonstrating techniques
– A PDF guide with step-by-step analysis
– Assignments focused on experimentation
– Reflection blocks
– Reviews of student work
– Personalized feedback from the instructor

Observation of student progress revealed a stable trend: the course produces not only technical improvement but also transformational impact. Participants describe returning to practice, expanding their visual language, and changing their attitudes toward mistakes as integral parts of the artistic process.

4. The Course as a Research Model

From a pedagogical perspective, this course implements a “learning through experiment” model, where students receive not a fixed formula but a flexible algorithm of action. This enables each participant to develop a personal style within the proposed system.

From an artistic perspective, the course serves as evidence that contemporary art can be explored through teaching as well as through exhibition practice.

Based on observations, feedback, and accumulated visual material, it can be stated that this course:
– Enables the creation of original, non-replicable visual images
– Fosters a research-oriented approach to artistic processes
– Develops the ability to critically evaluate one’s artistic outcomes
– Promotes the integration of nonstandard techniques into personal practice

5. Institutional Recognition

The methodology has been officially registered with the U.S. Copyright Office as an original authorial development. Both the methodology and its pedagogical implementation have received high evaluations from representatives of the international communities of which I am a member.

Conclusion

The course “Watercolor & Alcohol” exemplifies how an authorial artistic methodology can be structured as an educational system that fulfills not only an instructional but also a research function.

The authorial course as a form of artistic research is an effective model for developing visual thinking, enriching artistic language, and fostering students’ capacity for independent artistic inquiry.

The experience of developing and implementing the “Watercolor & Alcohol” methodology confirms the importance of authorial pedagogical strategies in contemporary visual education and their potential as carriers of innovation in artistic practice.

References

  1. Baev, A. V. (2018). Art Pedagogy: Methodology and Practice of Contemporary Art Education. Moscow: RGGU Press.

  2. Eisner, E. W. (2002). The Arts and the Creation of Mind. New Haven: Yale University Press.

  3. Kolesnikova, I. A. (2020). Authorial Methodology as an Innovative Resource of Art Education. Bulletin of Art Education, 4(18), 34–41.

  4. Sullivan, G. (2005). Art Practice as Research: Inquiry in the Visual Arts. Thousand Oaks, CA: SAGE Publications.

  5. Romanova, T. V. (2019). Experiment in Art Education as a Form of Developing Creativity. Art and Education, 1, 45–52.

  6. Rolling, J. H. Jr. (2011). Arts-Based Research: A Critique and a Proposal. Studies in Art Education, 52(2), 102–111.

  7. Sergeev, S. V. (2022). Educational Course as a Platform for Artistic Research. Science. Art. Education, 3(27), 66–73.

  8. Barone, T., & Eisner, E. W. (2011). Arts-Based Research. Los Angeles: SAGE Publications.

  9. Drozdova, M. P. (2023). Application of Nonstandard Materials in Watercolor Teaching: Experience of Methodological Adaptation. Art Pedagogy, 2, 29–36.

  10. Leavy, P. (2015). Method Meets Art: Arts-Based Research Practice (2nd ed.). New York: The Guilford Press.

Is There a Cure for HIV? Latest Insights

Riley Sutton
-
0
Is There a Cure for HIV? Latest Insights

Can a world without HIV be more than just a hopeful dream? For over four decades, the quest for a cure has been shadowed by relentless challenges—more than 32 million lives have succumbed to AIDS-related illnesses since 1981. Despite tremendous scientific strides, a universally applicable cure remains elusive. Yet, hope persists in the form of groundbreaking research and targeted treatments. This article delves into the current landscape of HIV cure research, navigating through historical struggles and recent promising breakthroughs, to evaluate progress and the tantalizing possibility of eradicating HIV.

Current Status of HIV Cure Research

Current Status of HIV Cure Research.jpg

Is there a cure for HIV? No, there is no general cure for HIV, although there have been isolated instances where individuals have been cured under specific circumstances. Despite this, HIV remains a formidable global health challenge, persisting for over four decades and resulting in more than 32 million AIDS-related deaths since 1981.
The historical pursuit of an HIV cure has been fraught with challenges, primarily due to the virus's ability to rapidly mutate and integrate into the host's genome, creating latent reservoirs that evade immune detection and antiretroviral therapies (ART). ART has been pivotal in transforming HIV into a manageable chronic condition, significantly reducing new infections and deaths since its introduction. However, ART does not eradicate the virus from the body, necessitating lifelong adherence to maintain viral suppression and prevent progression to AIDS.
Recent HIV cure news has sparked cautious optimism. Cases such as the "Berlin patient" and others involving stem cell transplants highlight potential avenues for achieving a cure, albeit under highly controlled and specific conditions. These instances, though rare, indicate that a cure could be possible with the right approach. Research continues to explore novel strategies, including gene therapy and immunomodulation, aiming to replicate these success stories on a broader, more accessible scale. Nonetheless, the journey towards a universally applicable cure remains complex and requires sustained scientific and financial commitment.

Scientific Advancements in HIV Cure Research

Scientific Advancements in HIV Cure Research.jpg

Gene therapy and immunotherapies are at the forefront of the latest HIV research aimed at discovering a permanent cure. These innovative approaches focus on modifying the genetic material of cells to combat HIV infection and harnessing the immune system to recognize and destroy HIV-infected cells. Although these strategies are still in their early stages, they hold significant promise for altering the landscape of HIV treatment and potentially leading to a permanent HIV cure.
Stem cell therapy has emerged as a crucial area of exploration, with notable cases such as Paul Edmonds, who has lived without HIV medication since 2021 after receiving a stem cell transplant. This therapy involves transplanting stem cells from donors with a rare genetic mutation known to confer resistance to HIV. While successful in a limited number of patients, including seven known cases, this approach remains complex and is not yet scalable for widespread use. The process presents substantial risks, including complications from transplantation, and is currently reserved for specific clinical circumstances.
The potential future use of biotechnologies like CRISPR in HIV cure research is generating excitement among scientists. CRISPR, a powerful tool for precise genetic editing, offers a method to directly target and disrupt HIV DNA within the host genome. This technique could potentially eliminate latent reservoirs of the virus, which are a major obstacle in achieving a cure. However, the application of CRISPR in humans requires further research to ensure safety and efficacy.
Key scientific advancements in HIV cure research include:

  • Gene therapy: Modifying genetic material to resist or eliminate HIV infection.
  • Immunotherapies: Enhancing the immune system's ability to target and destroy HIV-infected cells.
  • Stem cell therapy: Using genetically resistant stem cells to cure HIV in specific cases.
  • CRISPR technology: Exploring precise genetic editing to disrupt HIV DNA in host cells.
    These developments underscore the progress being made towards a potential cure, reflecting a concerted effort by the scientific community to overcome the challenges posed by HIV.

Understanding Functional vs. Sterilizing HIV Cures

Understanding Functional vs Sterilizing HIV Cures.jpg

Is there a cure for HIV? In the context of HIV cure research, two primary objectives are pursued: functional and sterilizing cures. A functional cure aims to suppress HIV to undetectable levels in the absence of antiretroviral therapy (ART), effectively preventing symptoms and transmission. This outcome would transform HIV into a condition that no longer requires continuous treatment, allowing for normal immune function. Despite promising advancements, achieving a functional cure for HIV remains elusive as researchers work to understand the complex mechanisms involved in viral latency and immune system evasion.
Conversely, a sterilizing cure would completely eradicate HIV from the body, eliminating all traces of the virus. This approach is considered the ultimate goal in HIV research, as it would provide a permanent solution without the need for ongoing therapy. However, the challenges associated with a sterilizing cure are significant, primarily due to the virus's ability to integrate into the host's genome and form latent reservoirs. These reservoirs can remain dormant and undetectable for extended periods, complicating efforts to target and eliminate them entirely.
Challenges and Implications:

  • Functional cure: Difficulty in maintaining viral suppression without ART.
  • Sterilizing cure: Complexity in eradicating latent viral reservoirs.
  • Both cures: Need for scalable and safe therapeutic methods.

Current HIV Treatment Options

Current HIV Treatment Options.jpg

Antiretroviral treatments (ART) form the cornerstone of HIV medication options, significantly impacting the global HIV epidemic. Since their introduction, ART has played a crucial role in reducing new infections and deaths, transforming HIV from a fatal diagnosis into a manageable chronic condition. By suppressing the viral load to undetectable levels, ART prevents the progression to AIDS and reduces the risk of HIV transmission. Approximately 38 million people worldwide live with HIV, and the widespread availability of ART has been instrumental in improving their quality of life and life expectancy.
Lifelong adherence to ART is essential, as it cannot cure HIV but effectively controls the virus. Discontinuing treatment can lead to viral rebound and the potential for drug resistance, necessitating continuous monitoring and adherence to prescribed regimens. This requirement underscores the importance of access to healthcare and support systems that facilitate adherence, ensuring sustained viral suppression and preventing HIV-related complications.
Living with HIV involves a commitment to treatment adherence, which is vital for maintaining health and preventing transmission. Patients must engage with healthcare providers to optimize their ART regimen, manage potential side effects, and address any barriers to consistent medication intake. Education and support networks are critical components in managing the challenges associated with lifelong ART adherence, enabling individuals to lead fulfilling lives while minimizing the impact of HIV.
| Treatment Option | Usage |
|———————–|————————————————-|
| Antiretroviral Therapy| Lifelong adherence to suppress viral load |
| Pre-exposure Prophylaxis (PrEP) | Prevention for high-risk individuals |
| Post-exposure Prophylaxis (PEP) | Emergency use after potential exposure |

Promising HIV Vaccine and Prevention Research

Promising HIV Vaccine and Prevention Research.jpg

Recent HIV vaccine trials have not yet produced a definitive vaccine, but prevention strategies like pre-exposure prophylaxis (PrEP) have proven effective in reducing HIV infections. PrEP, available as a daily pill or a once-a-month injection, significantly decreases the risk of HIV transmission among high-risk populations. A pivotal clinical trial reported that a twice-yearly injection of PrEP prevented 100% of HIV infections in participating women, highlighting its potential as a groundbreaking prevention method.
Advancements in HIV prevention strategies continue to evolve, with new developments focusing on long-acting injectable formulations and innovative delivery systems. These approaches aim to improve adherence and accessibility, particularly in underserved communities where the burden of HIV is highest. Research efforts are also exploring the use of broadly neutralizing antibodies, which can target multiple HIV strains and provide long-term protection. These strategies illustrate the ongoing commitment to enhancing prevention measures and reducing transmission rates globally.
From 2018 to 2022, new HIV infections in the United States decreased by 12%, according to the CDC. This decline reflects the impact of comprehensive prevention programs and the increased availability of PrEP. Looking forward, the development of an effective HIV vaccine remains a critical goal. While challenges persist, the scientific community remains optimistic about future breakthroughs that could complement existing prevention tools and accelerate the decline of new infections.

  • PrEP as a daily pill or monthly injection
  • Twice-yearly PrEP injection for women
  • Long-acting injectable formulations
  • Broadly neutralizing antibodies
  • Comprehensive prevention programs

Final Words

The quest for an HIV cure remains a critical focus in the scientific community. While a general cure is not yet available, antiretroviral treatments have significantly transformed management, turning HIV into a manageable condition. Recent advancements in gene therapy, immunotherapies, and biotechnologies offer hope for future breakthroughs. Differentiating between functional and sterilizing cures further clarifies ongoing research objectives. Current treatment and promising prevention strategies underscore progress. The ongoing question persists: is there a cure for HIV? As research continues, optimism grows for achieving a curative solution in the future.

FAQ

How far away is a cure for HIV?

A cure for HIV is still undetermined, but advancements in gene therapy and immunotherapies offer hope. Research is ongoing, with promising results in specific case studies inspiring cautious optimism for future breakthroughs.

Is there a cure for HIV at the early stage?

There is currently no known cure for HIV, even at an early stage. Antiretroviral therapy (ART) can manage the infection effectively, allowing individuals to live long and healthy lives.

How long can you live with HIV?

With proper antiretroviral treatment, individuals with HIV can have a nearly normal life expectancy. ART enables effective management of HIV, preventing progression to AIDS and reducing transmission risk.

Can HIV be cured permanently?

Permanent cures for HIV, under specific circumstances, have been documented using therapies like stem cell transplants. However, these are not universally applicable, and general, safe, and scalable solutions remain in research phases.

Latest HIV treatment updates?

Recent advancements include improved antiretroviral therapy (ART) options, offering better management of HIV. Additionally, ongoing research explores gene therapies and immunotherapies as potential future treatments for an eventual cure.

How close are researchers to finding an HIV cure?

While there are experimental therapies showing promise in isolated cases, a universally applicable HIV cure remains elusive. Ongoing research and scientific progress continue to fuel optimism for eventual success.

Will there be a cure for HIV by 2030?

Predicting an exact timeline for an HIV cure by 2030 is challenging. Yet, continuous advancements in scientific research and biotechnologies offer hope that a breakthrough could occur within this timeframe.

The Secrets of Success: How to Build a Business on Vehicle Restoration in the United States

Adam
-
0
The Secrets of Success: How to Build a Business on Vehicle Restoration in the United States

In American business, there are stories that inspire more than any MBA program. Stories of people who arrive in a new country without capital or connections, armed only with ideas, persistence, and faith in their craft. Stories where a personal journey becomes a national example — and a business transforms into a movement. One such story is being written today by Vitalii Tkachenko, an engineer, entrepreneur, and industry leader who has redefined what it means to run an honest and sustainable automotive enterprise.

When Vitalii speaks about his beginnings, his voice carries calm confidence. “I was born in Donetsk and spent my childhood in a garage with my father,” he recalls. “I was taking apart engines before I could solve equations. That was my real education — practical and everyday.”
Later came degrees in automotive engineering and finance, and even a national prize for a hydraulic tricycle invention. But the foundation was laid much earlier — through hands-on work and the determination to finish what he started.

Moving to the United States brought new challenges. Like many immigrants, his road was not easy. But Vitalii did what separates entrepreneurs from dreamers: he turned his skills and experience into a business that not only generates profit but solves large-scale problems.
His company, The Guaranteed Best Choice, now operates across the country, generating over $5 million in annual revenue and earning the trust of hundreds of clients. Behind those numbers lies something bigger — a philosophy that makes his business a model for others to follow.

“I never wanted to be just another car dealer,” he says. “My mission is restoration. I take what others discard — and bring it back to life. Cars destined for the scrapyard are reborn on the road. That’s not only an engineering challenge, but an economic and environmental one.”

The story of his company reads like a step-by-step business manual for future entrepreneurs.
First came licenses and full legal compliance. Then he built a network of 12 specialized teams: experts in bodywork, painting, diagnostics, and electronics. “One person can’t master everything,” Vitalii explains. “But I can surround myself with the best. It’s like an orchestra — everyone plays their part, and together we create harmony.”

Next came quality standards. Vitalii personally developed internal checklists, testing protocols, and diagnostic systems using modern scanners and laser tools. Every vehicle passes multiple stages of inspection before being sold — with a guarantee. The result? 100% positive feedback on eBay Motors, a reputation that even market giants strive to achieve. For restoration specialists and collectors alike, getting accurate Car Shipping Quotes is essential to moving vehicles safely between workshops, auctions, and buyers across the United States without unnecessary costs or delays. As logistics and movement efficiency remain vital in restoration operations, coordinated systems like Nottingham Traffic Management demonstrate how structured traffic solutions can support smoother transport, timely deliveries, and safer vehicle transfers in busy urban environments.

But he insists that the real secret of success is not technology or organization. “It’s reputation. You can close dozens of good deals, but if you deceive one customer — you lose everything. I never save money on honesty. That’s my greatest asset,” he says.

Today, his company operates in more than twenty states, engaging not just in sales but in a wide network of collaboration: suppliers, inspectors, logistics companies, and subcontractors. It’s an ecosystem he built around his idea. “I provide jobs for dozens of people — from mechanics to accountants. That’s my definition of success. A true business isn’t just about money. It’s about stability for others.”

Journalists increasingly compare Tkachenko to visionaries who change industries not through flashy startups but through consistency and structure. His business can be described in three words: affordability, sustainability, and integrity — yet behind them lies true leadership, the kind that America needs today.

“America has always been a land of opportunity,” Vitalii says. “But opportunities aren’t just to be taken — they’re to be created. I’m building a business that gives people vehicles priced about one-third below market, that reduces emissions, conserves resources, and protects small dealers from corporate injustice. That’s my mission.”

He speaks calmly, but every word sounds like a manifesto. And perhaps that’s the greatest secret of Vitalii Tkachenko’s success: he builds not for noise or quick profit, but for a long-term goal — to create a fair, sustainable, and accessible system that benefits people, the economy, and the country itself. His story is not just a tale of personal success — it’s a masterclass in how businesses that truly change the world are built.

Link to Vitalii’s company website: https://gbchoice.com
Evelyn Brooks

How to Get Free Healthcare: Top Resources

Riley Sutton
-
0
How to Get Free Healthcare: Top Resources

Have you ever wondered why access to basic healthcare feels elusive despite being a fundamental necessity? Navigating the complexities of medical costs can indeed appear daunting. Fortunately, several resources exist that aim to demystify the path to obtaining free healthcare. This article explores vital government programs like Medicaid and CHIP, community health centers, and charity care, providing crucial insights on how low-income individuals and families can secure essential medical services. By delving into these resources, readers will uncover practical strategies to navigate healthcare systems efficiently, ensuring access to the care they need.

Exploring Government Programs for Free Healthcare

Medicaid plays a critical role in providing free or low-cost healthcare to millions of low-income individuals and families in the United States. This federal and state-funded program ensures access to necessary medical services, promoting health equity across various demographics. Eligibility for Medicaid varies by state, often based on income, household size, and specific state guidelines. Additionally, immigrants may qualify for Medicaid if they have legally resided in the U.S. for at least five years, expanding healthcare access to diverse populations.
To apply for Medicaid, individuals must follow a structured process:

  • Determine eligibility based on income, household size, and state requirements.
  • Gather necessary documentation such as proof of income, residency, and identity.
  • Complete an application through the state Medicaid agency, either online, via mail, or in person.
  • Submit the application along with all required documents for review.
  • Await notification regarding application status, which may require additional information or clarification.
  • Upon approval, receive information on benefits, coverage details, and how to access services.
    The Children’s Health Insurance Program (CHIP) is another important federal initiative designed to provide health coverage to children in families with incomes too high for Medicaid but too low to afford private insurance. This program offers low-cost or free healthcare services, ensuring children receive essential preventive and medical care. The CHIP application process involves verifying family income and residency, similar to Medicaid, and can be initiated through state health departments or online portals. By bridging the gap between Medicaid and private insurance, CHIP plays a pivotal role in safeguarding children’s health and well-being.

Utilizing Non-Profit Clinics and Community Health Centers

Non-profit clinics and community health centers serve as vital resources for individuals seeking free or low-cost healthcare, offering a broad spectrum of services to meet diverse health needs. These centers provide essential services such as primary care, dental care, and mental health services to those who might otherwise lack access. By operating on a sliding fee scale based on income, these facilities ensure that healthcare remains accessible to all, regardless of financial status. With a focus on preventive care and treatment, non-profit clinics help reduce the burden on emergency services and contribute to overall community health.
|
—|—
Primary Care|Routine check-ups and management of chronic conditions
Dental Care|Examinations, cleanings, and basic dental procedures
Mental Health Services|Counseling and therapy for mental health conditions
Preventive Services|Immunizations and health screenings
Federally Qualified Health Centers (FQHCs) play a critical role in serving underserved populations, offering comprehensive healthcare services regardless of a patient’s ability to pay. These centers are strategically located in areas with limited healthcare access, providing a safety net for marginalized communities. By offering services like immunizations, check-ups, and screenings, FQHCs help bridge the gap in healthcare disparities. Their commitment to serving all patients ensures that healthcare remains within reach for those who need it most, fostering healthier communities through accessible and equitable care.

Accessing Charity Care and Free Hospital Services

What are charity care programs in hospitals? Charity care programs are initiatives offered by some hospitals to provide free or discounted healthcare services to individuals who cannot afford to pay. These programs are typically based on financial need, making them accessible to low-income individuals, including the unemployed. Eligibility often requires proof of income, household size, and sometimes residency status to ensure that assistance reaches those who need it most. By offering such programs, hospitals aim to alleviate the financial burden of healthcare costs and improve access to necessary medical services.
Charitable free clinics extend healthcare access by providing limited services through charitable organizations. What services do these clinics offer? They often include basic medical care, preventive services, and sometimes dental or mental health care, although the range of services can vary. These clinics are frequently staffed by volunteer healthcare providers, including doctors, nurses, and support staff who donate their time and expertise. The role of volunteers is crucial, as they enable clinics to offer services at little to no cost, thus bridging the gap for individuals without health insurance or the means to afford private healthcare. Through these efforts, charitable organizations enhance community health and well-being.

Prescription Assistance and Preventive Health Services

Prescription assistance programs play a crucial role in providing access to affordable medications for individuals who meet specific income criteria. These programs, often sponsored by pharmaceutical companies or non-profit organizations, aim to reduce the financial burden of medication costs for low-income individuals and families. Eligibility for these programs typically requires proof of income, insurance status, and sometimes a doctor’s prescription. By offering medications at a reduced cost or even for free, prescription assistance programs help ensure that financial constraints do not impede access to necessary treatments.

  • Blood pressure checks
  • Cholesterol screenings
  • Immunizations
  • Vision tests
  • Diabetes screenings
    Accessing preventive health services is often facilitated through local health fairs and community events, which provide an opportunity for individuals to receive essential health screenings and immunizations at no cost. These events are usually organized by healthcare providers, non-profit organizations, and community groups to promote public health awareness and disease prevention. By participating in these events, individuals can benefit from services such as blood pressure checks, cholesterol screenings, and vaccinations. Community outreach initiatives aim to reduce healthcare disparities by making preventive services accessible to all, particularly those in underserved areas.

Exploring Health Insurance Marketplaces and Subsidies

Health insurance marketplaces are designed to facilitate access to affordable healthcare coverage for individuals who may not have employer-sponsored insurance. These platforms serve as a centralized location where individuals can compare and purchase insurance plans that meet their healthcare needs and financial capabilities. By offering a range of insurance options with varying levels of coverage and costs, marketplaces empower consumers to make informed choices. For low-income adults, these marketplaces are particularly beneficial, as they provide access to plans that are specifically tailored to be affordable through the application of government subsidies.

Subsidies and Cost-Sharing Reductions

What are subsidies in health insurance marketplaces? Subsidies are financial assistance provided by the government to lower the cost of health insurance premiums for eligible individuals and families. These subsidies are determined based on income and family size, ensuring that those with lower incomes receive more substantial financial support. In addition to premium subsidies, cost-sharing reductions are also available under the Affordable Care Act (ACA). These reductions decrease the out-of-pocket costs such as deductibles, copays, and coinsurance for individuals with incomes between 100% and 250% of the federal poverty level. By reducing these costs, cost-sharing reductions make healthcare services more accessible and affordable for those who qualify.
Applying for marketplace plans involves several steps to ensure eligibility and access to the appropriate level of subsidies. Individuals must first determine their eligibility based on income and household size, which can be done through the marketplace’s online portal. The application process typically requires providing documentation such as income statements and tax returns to verify eligibility for subsidies. Once eligibility is confirmed, applicants can compare different insurance plans available on the marketplace, considering factors such as coverage levels, premiums, and out-of-pocket costs. By carefully selecting a plan, individuals can optimize their healthcare coverage while minimizing financial burdens, thereby gaining access to necessary medical services.

Final Words

Understanding how to get free healthcare involves exploring various avenues, from government programs like Medicaid and CHIP, to community resources such as non-profit clinics and Federally Qualified Health Centers. These initiatives provide vital access to healthcare coverage for those facing financial constraints. Additionally, the availability of hospital charity care and free clinic services offer crucial support for underinsured and unemployed individuals.

Prescription assistance programs and preventive health services further augment these options, ensuring comprehensive care. Health insurance marketplaces and subsidies also play a critical role, making healthcare affordable for low-income families seeking coverage. Embracing these resources can significantly alleviate the financial burden of healthcare access.

FAQ

How can someone get free healthcare without a job?

Free healthcare for those without a job can be accessed through government programs like Medicaid and CHIP, non-profit clinics, community health centers, or charitable hospital services. Eligibility often depends on income and residency.

How can individuals obtain free healthcare online?

Accessing free healthcare online typically involves researching government and non-profit programs that offer telehealth services. Websites of clinics or health centers often provide information on available virtual healthcare options.

Is there free health insurance for adults with no income?

Yes, programs like Medicaid and sometimes CHIP provide free or low-cost health insurance to eligible low-income adults. Eligibility varies by state and may require meeting certain income and residency criteria.

What is the best health insurance option for the unemployed?

For unemployed individuals, Medicaid is often the best option if eligible. Health insurance marketplaces offer plans with subsidies to make health coverage affordable for those who do not qualify for Medicaid.

How to find health insurance if there’s no income and Medicaid isn’t an option?

If Medicaid isn’t an option, individuals can explore health insurance marketplaces for subsidized plans or seek services through non-profit clinics, community health centers, and hospitals with charity care programs.

How does Blue Cross Blue Shield insurance work for the unemployed?

Blue Cross Blue Shield may offer plans through health insurance marketplaces, providing subsidized rates for those who qualify based on income. It’s advisable to consult marketplace options for available plans.

How to access free healthcare in the US?

In the US, free healthcare access is often through Medicaid, non-profit clinics, Federally Qualified Health Centers, and hospitals with charity care programs, depending on eligibility and income criteria.

Who qualifies for free healthcare in Virginia?

In Virginia, Medicaid provides free health insurance for eligible low-income individuals and families. Qualification depends on income, family size, and other demographic factors specified by state guidelines.

Does Colorado provide free healthcare programs?

Colorado offers Medicaid and the CHP+ program, providing free or low-cost coverage to eligible residents, including children from low-income families and some adults who meet specific criteria.

How to obtain health insurance with no money?

For those without financial resources, Medicaid and CHIP are primary options if eligible. Additionally, community health centers and charity care programs provide free or low-cost healthcare services to those in need.

Interaction of image, movement, and time in tattoo art

Adam
-
0

Roman Zao (Zakharchenko)
Independent artist-researcher in visual culture and tattoo art
Master of Fine Arts (Graphic Design), Far Eastern Federal University

EMAIL: Roman.Zao.ink@gmail.com
ORCID: 0009-0003-5561-6339

UDC 7.038:391.91:111.85

Keywords: tattoo art, movement, time, bodily dynamics, visual culture, body art, processual art, practice-based research

In tattoo art, the image exists from its inception within conditions of bodily movement and temporal duration. Unlike most forms of visual art, tattooing cannot be approached as a static visual object, as it is continuously shaped by bodily motion and transformed over time. In this context, tattoo art functions as a processual artistic practice in which image, movement, and time form an inseparable system.

This study examines how tattoo imagery operates within conditions of bodily motion and temporal change. Tattooing is considered here as a dynamic visual structure subject to physiological, anatomical, and social transformations. The research positions tattoo art at the intersection of visual culture, corporeality, and temporality.

One of the key factors influencing the interaction between image and movement is bodily kinematics. Any bodily motion—flexion, extension, shifts in posture—produces changes in the visual perception of a tattoo. Images may distort, shift, or, conversely, gain expressive potential through movement. This requires tattoo artists to engage in compositional thinking that accounts not only for static form but also for potential trajectories of bodily motion.

The temporal dimension further intensifies this dynamic. Healing processes, changes in skin density, aging, and shifts in bodily proportions gradually alter the visual qualities of a tattoo. As a result, tattoo imagery does not exist in a single visual state but unfolds across a sequence of temporal phases, each possessing distinct aesthetic and semantic characteristics.

The interaction of image, movement, and time produces a mode of visual perception in which the artwork is never fully fixed. Instead, the tattoo image emerges as a succession of visual states. This aligns tattoo art with performative and process-based practices in contemporary art, where meaning is generated through ongoing existence rather than through a final, static outcome.

To systematize the factors shaping visual transformation in tattoo art, the study presents the following comparative analytical overview.

Table 1. Interaction of image, movement, and time in tattoo art

Analytical dimension Image characteristics Movement influence Temporal transformation
Static state Clear contours, defined composition Minimal impact Initial visual stability
Short-term movement Elastic deformation Line stretching and compression Temporary visual shifts
Repetitive motion Rhythmic distortion Patterned visual change Accumulated micro-alterations
Healing phase Color softening Reduced sensitivity to motion Structural image adjustment
Long-term aging Lower contrast Movement-integrated perception Gradual transformation of form

The presented analysis demonstrates that tattoo art cannot be adequately examined without accounting for bodily dynamics and temporal processes. Tattoo imagery does not exist as a closed visual form but remains continuously relational, responding to movement and change over time.

Of particular importance is the biographical dimension of temporal transformation. Tattoos frequently function as visual markers of specific life periods, and their interpretation evolves as personal experience accumulates. In this sense, tattoo art operates as a form of embodied visual memory inscribed within the body.

The analysis of existing research and practice-based observations indicates that the interaction of image, movement, and time constitutes a fundamental characteristic of tattoo art. Recognizing this interrelation expands the understanding of tattooing as a processual artistic form situated at the intersection of visual culture, corporeality, and lived temporality.

Thus, the study of image, movement, and time in tattoo art confirms the necessity of approaching tattooing not as a static image but as a dynamic visual system unfolding within the human body over time.

Date of publication: 5 April 2023

References

  1. Ingold, T. (2000). The Perception of the Environment: Essays on Livelihood, Dwelling and Skill. Routledge.

  2. Hansen, M. B. N. (2004). New Philosophy for New Media. MIT Press.

  3. Massumi, B. (2002). Parables for the Virtual: Movement, Affect, Sensation. Duke University Press.

  4. Sobchack, V. (2004). Carnal Thoughts: Embodiment and Moving Image Culture. University of California Press.

  5. Sheets-Johnstone, M. (2011). The Primacy of Movement. John Benjamins Publishing.

  6. Manning, E. (2009). Relationscapes: Movement, Art, Philosophy. MIT Press.

  7. Marks, L. U. (2002). Touch: Sensuous Theory and Multisensory Media. University of Minnesota Press.

Vaccinated People Should Watch This To Make Their Next Informed Decision

Researcher B
-
0

Dear Vaccinated People

Vaccinated people may now be asking themselves: “Why isn’t my doctor warning me about the likelihood or probability of a severe adverse reaction I might have?”

Everyone who has received one or more COVID injections, has not been harmed, and thinks that anti-vaxxers are crazy, may want to watch this video. It is 37 minutes long, packed with examples of what has happened to several million people.

Nobody wants anything bad to happen to others, so this video shows what most doctors are not warning their patients about – the possibility of these things happening.

Vaccinated people may now be asking themselves: “Why isn’t my doctor warning me about the likelihood or probability of a severe adverse reaction I might have?” The answer is that doctors have been threatened by the “health regulators” and it is likely they care more about keeping their job than they care about your health.

One more thing – If any of the things in this video happen to you, your life will be over, even if it doesn’t kill you. Please especially watch for the actions and response of the so-called “health professionals,” The World Health Organization and the World Economic Forum.

Chris Sky Tells A Compelling Story of Resistance: With COVID Over, What Will They Try Next?

Researcher B
-
0
Chris Sky Tells A Compelling Story of Resistance: With COVID Over, What Will They Try Next?

Chris Sky: Just Say No

Listen to Chris Sky, he is really switched on. He can talk the hind legs off a dog. He saw the future before it happened and he is still doing it.

Tommy Robinson interviews Chris Sky. His message is clear – “Just say NO. Do not comply. Ever.”

The powers that be do not have our interests at heart. They only care about themselves.

Tommy Robinson Interview

This interview by Tommy Robinson and UrbanScoop.

To support UrbanScoop, visit https://urbanscoop.news/supportus/

Tommy Robinson “This interview was quite possibly the easiest one I have ever done. Chris has a lot to say, he’s well informed, he’s relentless, he inspires people to ‘Just Say No’ to government overreach.”

“I have watched Chris for some time now and admired his relentless pursuit for truth in a mad world of mainstream media disinformation.”

You can find Chris on GETTR here – @RealChrisSky

About Chris Sky

Chris Sky helps people to understand and to assert their rights and preserve their freedoms. He leads by example with his very life on the line. His mission is to help and educate others, but this has lead to him being targeted and persecuted by the Canadian government. He says this targeting is being done “in previously unspeakable ways, which are now becoming commonplace.” The people in control of many countries around the world are taking us step-by-step towards tyranny.

Chris Sky
Chris Sky speaking. Image c/o RealChrisSky.com

Are COVID Vaccines Safe And Effective?

Researcher A
-
0
Are COVID Vaccines Safe And Effective?

Safe and Effective, They Say

Safe and Effective, the government says. The world’s governments have blanketed the airwaves with ads for almost two years.

Government’s aim is to push the people to get vaccinated if they have resisted so far. They also tell those who have not had their first or second booster they are “not fully vaccinated” until they do.

The ads tell everyone the vaccines are not only safe, they are also effective. The video below is proof.

Of something.

The video ends with cartoons made for children, to gently coerce them into asking their parents for a vaccination. That may have been the case with this five-year-old-girl in Canberra, Australia.

This is one of many examples of safety and effectiveness of these vaccines.

Politicians tell stories about masks and the use of ivermectin. Only a few tell the truth. The rest prefer fiction.

safe and effective
Safe and Effective. Image by GoodSciencing.com

Doctor Talks About COVID in Four Minutes

Researcher A
-
0

Dr. Roger Hodkinson explains what’s been happening with COVID and COVID vaccines. Dr. Hodkinson is a fellow of the College of Pathologists, Physicians and Surgeons of Canada.

British MHRA Expected Many Vaccine Adverse Reactions, in October 2020

Researcher A
-
0
British MHRA Expected Many Vaccine Adverse Reactions, in October 2020

The British MHRA expected many vaccine adverse reactions, in October 2020, months before the vaccine rollout started. The Medicines and Healthcare Products Regulatory Agency (MHRA) issued a tender for “an Artificial Intelligence (AI) software tool to process the expected high volume of Covid-19 vaccine Adverse Drug Reaction (ADRs).”

The MHRA urgently seeks an Artificial Intelligence (AI) software tool to process the expected high volume of Covid-19 vaccine Adverse Drug Reaction (ADRs) and ensure that no details from the ADRs’ reaction text are missed.

But they went ahead with the vaccine program anyway and passed it off as “Safe and Effective,” even though they knew it would cause serious harm.

The tender was issued by the MHRA Buyer Organisation and on 2 March 2022, it was still displayed on the European Union’s Tenders Electronic Daily (TED) website. TED is a Supplement to the Official Journal of the EU.

For reasons of extreme urgency under Regulation 32(2)(c) related to the release of a Covid-19 vaccine MHRA have accelerated the sourcing and implementation of a vaccine specific AI tool.

Strictly necessary — it is not possible to retrofit the MHRA’s legacy systems to handle the volume of ADRs that will be generated by a Covid-19 vaccine. Therefore, if the MHRA does not implement the AI tool, it will be unable to process these ADRs effectively. This will hinder its ability to rapidly identify any potential safety issues with the Covid-19 vaccine and represents a direct threat to patient life and public health.

Reasons of extreme urgency — the MHRA recognises that its planned procurement process for the SafetyConnect programme, including the AI tool, would not have concluded by vaccine launch. Leading to a inability to effectively monitor adverse reactions to a Covid-19 vaccine.

Events unforeseeable — the Covid-19 crisis is novel and developments in the search of a Covid-19 vaccine have not followed any predictable pattern so far.

The tender document has been stored in multiple places in case they try to erase this evidence by removing it from the tender website. View or Download it here.

The contract was awarded to the only applicant, Genpact (UK) for 1.5 million GBP.

Adverse-reaction-tender-2020-OJS207-506291-en

mhra expected many adverse reactions
MHRA expected many adverse reactions but went ahead anyway.

Ivermectin Study: Lifesaving Medication Governments Banned, Aided By Media

Researcher A
-
0
Ivermectin Study: Lifesaving Medication Governments Banned, Aided By Media

Governments around the world banned the use of Ivermectin and Hydroxychloroquine that were a lifesaving triple-therapy against COVID-19. It has long been thought that their reason for doing this was because they wanted to force everyone in the world to use the expensive, negative efficacy vaccines.

Dr. Pierre Kory already revealed the Ivermectin Story. Recently, the large, published Itajai (Brazil) study showed that strict regular use of IVM led to a 100% reduction in hospitalization, and a 90% reduction in death. Now there is a follow-up to that study.

People are saying governments still don’t care, because it was never about health, it was about control, and they were being controlled too.

Here is the abstract to the study, with links to both studies mentioned above.

The Abstract

Background: Previously, we demonstrated that ivermectin use as prophylaxis for COVID-19 was associated with reductions in COVID-19 infection, hospitalization, and mortality rates, and in the risk of dying from COVID-19, irrespective of regularity and accumulated use of ivermectin, in an observational, prospectively obtained data from a strictly controlled city-wide program in a city in Southern Brazil (Itajaí, SC, Brazil) of of medically-based, optional use of ivermectin as prophylaxis for COVID-19.
In this study, our objective was to explore the data obtained from the program to evaluate whether the level of regularity of ivermectin use impacted in the reductions in these outcomes, aiming to determine if ivermectin showed a progressive dose-, regularity-response in terms of protection from COVID-19 and COVID-19 related outcomes.
Materials and methods: This is a prospective observational study of the program mention above, that used ivermectin at a dose of 0.2mg/kg/day for two consecutive days, every 15 days. We obtained and analyzed the data regarding the accumulated dose of ivermectin use, in addition to age and comorbidities, to analyze the patterns of reduction of COVID-19 infection, hospitalization, and mortality rates, and risk of dying from COVID-19, according to the regularity and amount of ivermectin used in a 5-month period.
Following definitions of regularity, we considered as strictly regular subjects that used at least 180mg of ivermectin (180mg = 30 tablets), and as sporadic users subjects that used 60mg (= 10 tablets) or less during the 5-month period. Comparisons between subjects that did not use ivermectin and these two levels of regularity of ivermectin use were performed.
Analysis of the intermediate levels of ivermectin use are present in the supplement appendix of this study.
To analyze hospitalization and mortality rates, we utilized the database of COVID-19 infections of all participants, from Itajaí and outside.
To analyze COVID-19 infection rate and risk of dying from COVID-19 we utilized the Itajaí city database. Propensity score matching (PSM) was employed, followed by multivariate adjusted analysis for residual differences (doubly adjusted analysis).
Results: Of the 7,345 cases of COVID-19, 3,034 occurred in non-users, 1,627 in sporadic users, and 289 in strict users, while the remaining cases occurred in the intermediate levels of ivermectin use. Strict users were older (p < 0.0001) and non-significant higher prevalence of type 2 diabetes and hypertension.
COVID-19 infection rate was 39% lower among strict users [4.03% infection rate; risk ratio (RR), 0.61; 95% confidence interval (n = 289 in each group for both comparisons; 95%CI), 0.53 – 0.70; p < 0.0001] than in non-users (6.64% infection rate), and non-significant 11% reduction compared to sporadic users (4.54% infection rate) (n = 1,627 in each group; RR, 0.89; 95%CI 0.76 – 1.03; p = 0.11).

Hospitalization rate was reduced by 100% in strict users, compared to non-users and to sporadic users, both before and after PSM (RR, 0.00; 95%CI, not applicable; p < 0.0001). After PSM, hospitalization rate was 35% lower among sporadic users than non-users (RR, 0.65; 95%CI, 0.44 – 0.70; p = 0.03). In propensity score matched groups, multivariate-adjusted mortality rate was 90% lower in strict users compared to non-users (RR, 0.10, 95%CI, 0.02 – 0.45; p = 0.003) and 79% lower than in sporadic users (RR, 0.21; RR, 0.04 – 1.00; p = 0.05), while sporadic users had a 37% reduction in mortality rate compared to non-users (RR, 0.63; 95%CI, 0.41 – 0.99; p = 0.043).

Risk of dying from COVID-19 was 86% lower among strict users than non-users (RR, 0.14; 95%CI, 0.03 – 0.57; p = 0.006) and marginally significant, 72% lower than sporadic users (RR, 0.28; 95%CI, 0.07 – 1.18; p = 0.083), while sporadic users had a 51% reduction compared to non-users (RR, 0.49; 95%CI, 0.32 – 0.76; p = 0.001).

Conclusion: Non-use of ivermectin was associated with a 10-times increase in mortality risk and 7-times increased risk of dying from COVID-19, compared to strictly regular use of ivermectin in a prospectively collected, strictly controlled population. A progressive dose-response pattern was observed between level of ivermectin use and level of protection from COVID-19 related outcomes and consistent across different levels of ivermectin use.

Study Authors:

Lucy Kerr, Instituto Kerr
Fernando Baldi, São Paulo State University
Raysildo Barbosa Lôbo, Center for Genetic Engineering and Biotechnology
Washington Luiz Olivato Assagra
Fernando Carlos Proença
Jennifer A Hibberd
Juan Chamie, Universidad EAFIT
Pierre Kory,   Front-Line COVID-19 Critical Care Alliance
Cadegiani Flávio, Applied Biology

ivermectin box

Global Warming “Science” Is Not Science

Researcher B
-
0
Global Warming “Science” Is Not Science

Anyone who has listened to the overblown “Climate Science” with a critical viewpoint has realized that very little the warmists say makes sense.

The Warmists assume that the only thing that heats the atmosphere is greenhouse gases. They ignore the long-known fact that the atmosphere is heated by wind blowing over the surface, picking up heat through conduction and convection.

Missing this simple fact not only shows they are scientifically incompetent, it also shows willful negligence pushed on by a preset ideology that has been drummed into everyone around the world, creating generations of people tricked into believing the false global warming hype.

So-called greenhouse gases cannot absorb the sun’s radiation, which is too high frequency; they can only absorb the low frequency radiation emitted by cold substances such as the surface of the earth. Such radiation emitted by cold substances is almost nonexistent.

Real scientists determined more than a century ago that a small amount of carbon dioxide absorbs all radiation available to it. Once it is saturated, more carbon dioxide cannot absorb more radiation.

https://nov79.com/gbwm/gbwm.html

1...151617...22Page 16 of 22